Skip to main content

Industry News

  • Voluntary recall of a number of drugs have been initiated by Sun Pharma and Wockhardt from the US market due to different reasons.

    Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-release Tablets USP (SR), 200 mg, 60-count bottle for "failed dissolution specification", while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg for "CGMP violations".

  • The Mankind Pharma has taken an initiative to spread awareness about the importance of having strong bones, among the masses. The company has been championing this cause with their specialized ‘D3 Must Campaign’ across the country by reaching out to various schools, institutes and corporates.

  • Siemens Healthcare has launched three new scalable haematology systems: the ADVIA 360 System, ADVIA 560 System and ADVIA 560 AL System.
    The systems offer fast, high quality CBC testing, running up to 60 samples per hour. Automatic anti-clogging and cleaning procedures are employed to ensure results reliability. Along with automated maintenance, this reduces manual procedures and biohazard exposure. Other features include option for manual or automatic calibration procedures, a cap-piercing function for accurate and safer sampling, a multilingual operating menu and bidirectional LIS communication for easy patient data transfer between laboratories and minimised paper-based work lists.

  • Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid heat elution purification technology to Roche. Roche has signed a definitive asset purchase agreement with Lumora for products associated with its proprietary nucleic acid heat elution purification technology that is designed for use with clinical specimens.

  • Pfizer Inc, one of the world's premier innovative biopharmaceutical companies, announced that the US Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to company's pending acquisition of Hospira.

  • A health exchange portal called Zigy.com was launched by former iGate CEO Phaneesh Murthy-founded PM Health and Life Care (PMHLC) on August 24. Zigy.com connects patients requiring health products and services with doctors, hospitals, chemists, diagnostic labs and also provides wellness products and services, insurance, home-care services and alternative medicines. However, Zigy does not allow patients to order medicines without a genuine prescription. Zigy.com is availabe as a website and a mobile app as well.

  • Global Expansion: Opportunities in the U.S for Indian Companies

    (Business Wire India); Brickwork India, the India representative of Fairfax County Economic Development Authority (FCEDA) organized the seminar on Global Expansion in Bangalore on July 23rd 2015. The seminar, conducted with the Indo-American Chamber of Commerce (IACC), highlighted the business opportunities in Fairfax County, Virginia – just outside Washington, DC – for Indian firms with IT services and solutions for the Cloud Computing, Big Data Analytics and Defence and Aerospace domains.

  • Ajanta Pharma, a Rs. 1,450 crore plus Mumbai based pharma major, has received the third largest wealth creator award from Fortune India. Fortune India has published list of 500 mid-size companies and ranked them on various parameters based on the results of 2013-14. Similarly, Ajanta Pharma ranked tenth on return on capital employed, 21st in net profit and 182nd in sales.

    [adsense:336x280:8701650588]

Subscribe to Industry News